Ellen H.M. Moors
Title
Cited by
Cited by
Year
A network of heterogeneous hydrogen bonds in GNRA tetraloops
FM Jucker, HA Heus, PF Yip, EHM Moors, A Pardi
Journal of molecular biology 264 (5), 968-980, 1996
3761996
Towards cleaner production: barriers and strategies in the base metals producing industry
EHM Moors, KF Mulder, PJ Vergragt
Journal of cleaner production 13 (7), 657-668, 2005
1782005
Traditional and modern technology assessment: toward a toolkit
J Van Den Ende, K Mulder, M Knot, E Moors, P Vergragt
Technological Forecasting and Social Change 58 (1-2), 5-21, 1998
1571998
Clinical comparability and European biosimilar regulations
H Schellekens, E Moors
Nature biotechnology 28 (1), 28-31, 2010
1142010
Demand articulation in emerging technologies: intermediary user organisations as co-producers?
WPC Boon, EHM Moors, S Kuhlmann, REHM Smits
Research Policy 40 (2), 242-252, 2011
1092011
Science, technology and the ‘grand challenge’of ageing—Understanding the socio-material constitution of later life
A Peine, A Faulkner, B Jæger, E Moors
Technological Forecasting and Social Change 93, 1-9, 2015
842015
Demand articulation in intermediary organisations: The case of orphan drugs in the Netherlands
WPC Boon, EHM Moors, S Kuhlmann, REHM Smits
Technological forecasting and social change 75 (5), 644-671, 2008
772008
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
PJK van Meer, M Kooijman, V Brinks, CC Gispen-de Wied, B Silva-Lima, ...
MAbs 5 (5), 810-816, 2013
732013
Exploring emerging technologies using metaphors–a study of orphan drugs and pharmacogenomics
W Boon, E Moors
Social science & medicine 66 (9), 1915-1927, 2008
652008
Technology strategies for sustainable metals production systems: a case study of primary aluminium production in The Netherlands and Norway
EHM Moors
Journal of cleaner production 14 (12-13), 1121-1138, 2006
602006
Caring for healthcare entrepreneurs—Towards successful entrepreneurial strategies for sustainable innovations in Dutch healthcare
M Janssen, EHM Moors
Technological Forecasting and Social Change 80 (7), 1360-1374, 2013
582013
The dynamics of innovation: a multilevel co-evolutionary perspective
EHM Moors, A Rip, JSC Wiskerke
Koninklijke Van Gorcum, 2004
582004
Institutional power play in innovation systems: The case of Herceptin®
P Kukk, EHM Moors, MP Hekkert
Research Policy 45 (8), 1558-1569, 2016
542016
The ability of animal studies to detect serious post marketing adverse events is limited
PJK van Meer, M Kooijman, CC Gispen-de Wied, EHM Moors, ...
Regulatory Toxicology and Pharmacology 64 (3), 345-349, 2012
532012
Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe
WPC Boon, EHM Moors, A Meijer, H Schellekens
Clinical Pharmacology & Therapeutics 88 (6), 848-853, 2010
522010
Exploring dynamics and strategies of niche protection
WPC Boon, EHM Moors, AJ Meijer
Research Policy 43 (4), 792-803, 2014
462014
User producer interaction in context
R Nahuis, EHM Moors, REHM Smits
Technological Forecasting and Social Change 79 (6), 1121-1134, 2012
452012
Towards a sustainable system of drug development
EHM Moors, AF Cohen, H Schellekens
Drug discovery today 19 (11), 1711-1720, 2014
432014
Conceptualizing patterns in the dynamics of emerging technologies: The case of biotechnology developments in the Netherlands
T Van der Valk, EHM Moors, MTH Meeus
Technovation 29 (4), 247-264, 2009
402009
Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: a sociotechnical analysis
R Achterbergh, P Lakeman, D Stemerding, EHM Moors, MC Cornel
Health Policy 83 (2-3), 277-286, 2007
352007
The system can't perform the operation now. Try again later.
Articles 1–20